Since the PI3K/Akt and PLC/PKC pathways are crucial for regulating cell survival, proliferation, migration, and invasion [57,58], the anti-tumor activity of rAj-HRP may be attributed to its inhibition of EGFR and its downstream pathways. The gene discussed is HSPG2; the disease is neoplasm.